Ginkgo Bioworks
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $56,206 | $37,944 | $34,755 | $55,430 |
Gross Profit | 25,155 | 15,873 | 18,807 | 48,507 |
EBITDA | -133,199 | -145,868 | -141,617 | -39,049 |
EBIT | -150,529 | -158,737 | -154,454 | -68,417 |
Net Income | -217,181 | -165,911 | -211,694 | -302,891 |
Net Change In Cash | 56,206 | 37,944 | 34,755 | 55,430 |
Free Cash Flow | -111,422 | -95,969 | -52,000 | -77,932 |
Cash | 732,720 | 843,768 | 944,073 | 1,049,244 |
Basic Shares | 51,375 | 50,133 | 50,032 | 48,770 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $251,455 | $477,706 | $313,837 | $76,657 |
Gross Profit | 142,643 | 273,490 | 184,147 | 61,046 |
EBITDA | -600,677 | -2,180,394 | -1,877,571 | -107,515 |
EBIT | -672,231 | -2,242,028 | -1,877,807 | -121,379 |
Net Income | -892,869 | -2,104,929 | -1,836,642 | -126,609 |
Net Change In Cash | 251,455 | 477,706 | 313,837 | 76,657 |
Cost of Revenue | -224,255 | 1,207,070 | ||
Free Cash Flow | -336,301 | -304,469 | -310,339 | -193,651 |
Cash | 948,862 | 1,315,792 | 1,550,004 | 380,801 |
Basic Shares | 48,610 | 41,995 | 1,611,392 | 1,485,061 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$2.80 |
2024-03-31 | -$0.08 |
2023-12-31 | -$0.11 |
2023-09-30 | -$0.16 |
